Herbs (Global Traditional) · European
Laurus nobilis (Bay Leaf)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Bay leaf (Laurus nobilis) contains bioactive sesquiterpenes and phenolic compounds that provide antioxidant and antimicrobial effects. The ethanolic extracts demonstrate 75% ABTS radical scavenging activity through polyphenol-mediated free radical neutralization.
Laurus nobilis, commonly known as bay leaf, is an evergreen tree native to the Mediterranean region belonging to the Lauraceae family. The dried leaves are processed through various extraction methods including maceration, Soxhlet, microwave-assisted extraction (MAE), ultrasound-assisted extraction (UAE), or supercritical fluid extraction (SFE) using solvents like methanol, ethanol, or water mixtures to obtain polyphenol-rich extracts.
No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Laurus nobilis leaf extracts were found in the research. Evidence is limited to in vitro antioxidant assessments and extraction optimization studies, with no PubMed PMIDs for human studies available.
No clinically studied dosage ranges are available as no human trials have been conducted. Laboratory extraction yields include 22.3% for Soxhlet ethanolic extraction and total phenolic content ranging from 4-75 mg GAE/g depending on extraction method. Consult a healthcare provider before starting any new supplement.
Per 100 g dried bay leaves (approximate values): Energy: 313 kcal; Protein: 7.6 g; Total fat: 8.4 g; Carbohydrates: 48.7 g (dietary fiber: 26.3 g); Water: 5.4 g. **Minerals:** Calcium: 834 mg; Iron: 43 mg; Magnesium: 120 mg; Manganese: 8.2 mg; Phosphorus: 113 mg; Potassium: 529 mg; Zinc: 3.7 mg; Sodium: 23 mg. **Vitamins:** Vitamin A (as β-carotene): ~6,185 IU; Vitamin C: 46.5 mg; Niacin (B3): 2.0 mg; Pyridoxine (B6): 1.74 mg; Riboflavin (B2): 0.42 mg; Folate: 180 µg. **Key bioactive compounds:** 1,8-Cineole (eucalyptol): 30–50% of essential oil fraction (major monoterpenoid; primary aromatic and bioactive volatile); Linalool: 5–12% of essential oil; α-Terpinyl acetate: 5–10% of essential oil; Eugenol: 1–5% of essential oil; Methyl eugenol: trace–2% of essential oil. **Sesquiterpene lactones:** Costunolide and dehydrocostus lactone (present in low mg/g range in dried leaf; associated with cytotoxic and anti-inflammatory activity in vitro). **Polyphenolics and flavonoids:** Catechins, kaempferol (≈0.2–0.5 mg/g dry weight), quercetin glycosides, and rutin (collectively contributing to measured antioxidant capacity). **Proanthocyanidins and tannins:** Present at approximately 1.5–3% of dry weight. **Lauric acid:** Present in trace quantities in leaves (more concentrated in fruit/berry). **Bioavailability notes:** Typical culinary use involves 1–3 whole leaves per dish (approximately 0.5–2 g), so actual nutrient intake from bay leaf as a seasoning is minimal for macronutrients and minerals. However, volatile terpenoids (especially 1,8-cineole) are efficiently released during simmering and are absorbed via inhalation and ingestion. Polyphenolic compounds have moderate oral bioavailability, limited by first-pass hepatic metabolism and low aqueous solubility, though extraction into aqueous/fat-based cooking media enhances release. Iron content is high per 100 g but is non-heme and subject to low absorption rates (2–10%), further limited by the small quantities consumed.
Bay leaf's phenolic compounds neutralize free radicals by donating hydrogen atoms to ABTS radicals, achieving 75% scavenging activity. The sesquiterpene lactones disrupt microbial cell membrane integrity through lipid peroxidation. These compounds may also interfere with cellular proliferation pathways, though the exact cytotoxic mechanisms require further investigation.
Current evidence for bay leaf is limited to in vitro laboratory studies rather than human clinical trials. Ethanolic extracts showed 75% ABTS radical scavenging activity in antioxidant assays, while antimicrobial studies demonstrated leavuricidal effects against specific pathogens. Preliminary research identified six sesquiterpene compounds with potential cytotoxic properties, but no human studies have validated these effects. Clinical trials are needed to establish therapeutic dosages and confirm bioavailability in humans.
Bay leaf is generally recognized as safe when used as a culinary spice, but concentrated extracts may pose risks due to sesquiterpene content. Potential drug interactions may occur with anticoagulant medications due to coumarin compounds. Pregnant and breastfeeding women should avoid therapeutic doses beyond culinary use due to insufficient safety data. Allergic reactions are possible in individuals sensitive to the Lauraceae plant family.
